CAPLYTA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Intra-cellular Therapies, Inc. The primary component is Lumateperone.
Product ID | 72060-121_574a3159-32b9-42b8-a653-bee24406fe38 |
NDC | 72060-121 |
Product Type | Human Prescription Drug |
Proprietary Name | CAPLYTA |
Generic Name | Lumateperone |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2022-08-09 |
Marketing Category | NDA / |
Application Number | NDA209500 |
Labeler Name | Intra-Cellular Therapies, Inc |
Substance Name | LUMATEPERONE |
Active Ingredient Strength | 21 mg/1 |
Pharm Classes | Atypical Antipsychotic [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-08-09 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
70518-3497 | CAPLYTA | lumateperone |
72060-110 | CAPLYTA | lumateperone |
72060-121 | CAPLYTA | lumateperone |
72060-142 | CAPLYTA | lumateperone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() CAPLYTA 88742518 not registered Live/Pending |
INTRA-CELLULAR THERAPIES, INC. 2019-12-30 |
![]() CAPLYTA 88742498 not registered Live/Pending |
INTRA-CELLULAR THERAPIES, INC. 2019-12-30 |
![]() CAPLYTA 88340176 not registered Live/Pending |
INTRA-CELLULAR THERAPIES, INC. 2019-03-14 |
![]() CAPLYTA 87334055 not registered Live/Pending |
INTRA-CELLULAR THERAPIES, INC. 2017-02-13 |